Jubilant Therapeutics Appoints Dr. Robert Glassman to its Board of Directors

BEDMINSTER, N.J., Feb. 5, 2021 -- (Healthcare Sales & Marketing Network) -- Jubilant Therapeutics Inc., a biopharmaceutical company advancing small molecule modulators to address unmet medical needs in oncology and autoimmune diseases, today announced the... Biopharmaceuticals, Oncology, Personnel Jubilant Therapeutics
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news